search
Back to results

Comprehensive Swallowing Rehabilitation in Patients With MSA

Primary Purpose

Multiple System Atrophy

Status
Recruiting
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Comprehensive swallowing rehabilitation
Swallowing education
Sponsored by
Seoul National University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Multiple System Atrophy focused on measuring Multiple System Atrophy, Dysphagia, Swallowing rehabilitation, Videofluoroscopic Swallowing Study

Eligibility Criteria

19 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age >19 years
  • Clinically diagnosed with MSA according to the guidelines of the 2nd consensus of the Gilman criteria
  • Clinically diagnosed to have dysphagia by a physiatrist
  • Two or more points on the Penetration-aspiration scale (PAS) from the Videofluoroscopic swallowing study (VFSS) conducted within 3 months

Exclusion Criteria:

  • Moderate to severe cognitive dysfunction with Mini-mental State Examination score < 19
  • Comorbidities or structural abnormalities that may affect swallowing function
  • Other comorbidities that make it difficult to participate in the study

Sites / Locations

  • Seoul National University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Comprehensive swallowing rehabilitation

Swallowing education

Arm Description

Outcomes

Primary Outcome Measures

Penetration-Aspiration Scale
Videofluoroscopic dysphagia scale

Secondary Outcome Measures

Penetration-Aspiration Scale
Videofluoroscopic dysphagia scale
Peak Cough Flow
Maximal Inspiratory Pressure
Maximal Expiratory Pressure
Forced vital capacity
Forced expiratory volume
Maximal phonation time
Swallowing disturbance questionnaire
Swallowing Quality of Life questionnaire

Full Information

First Posted
March 1, 2021
Last Updated
October 24, 2022
Sponsor
Seoul National University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04782284
Brief Title
Comprehensive Swallowing Rehabilitation in Patients With MSA
Official Title
Effect of Comprehensive Swallowing Rehabilitation in Patients With Multiple System Atrophy: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
May 17, 2021 (Actual)
Primary Completion Date
May 30, 2024 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seoul National University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to investigate the effect of comprehensive swallowing rehabilitation in patients with multiple system atrophy.
Detailed Description
Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease characterized by parkinsonism, cerebellar syndrome, and autonomic failure. Dysphagia is a clinically significant symptom leading to pneumonia that causes death in patients with MSA. Although the symptoms of dysphagia in the two subtypes of MSA-the parkinsonian variant and the cerebellar variant- are different, there is no significant difference in the latency to onset of tube feeding. Therefore, effective intervention is needed to improve the safety and efficiency of swallowing regardless of the subtypes of MSA. Although swallowing rehabilitation has been widely applied for swallowing disorders in patients with MSA, few studies have reported the clinical effect of applying swallowing therapy. Comprehensive swallowing rehabilitation has focused on functional muscle training, compensatory swallowing maneuvers, and thermal-tactile stimulation, which is used to treat dysphagia from stroke, Parkinson's disease, and head and neck cancer. Therefore, this study aims to investigate the effect of comprehensive swallowing rehabilitation in patients with MSA.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple System Atrophy
Keywords
Multiple System Atrophy, Dysphagia, Swallowing rehabilitation, Videofluoroscopic Swallowing Study

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A randomized controlled trial
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
24 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Comprehensive swallowing rehabilitation
Arm Type
Experimental
Arm Title
Swallowing education
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Comprehensive swallowing rehabilitation
Intervention Description
The treatment time per session is 30 minutes. Total 12 sessions are provided for 6 weeks.
Intervention Type
Other
Intervention Name(s)
Swallowing education
Intervention Description
The education is 30 minutes. Total 1 session is provided immediately after baseline evaluation.
Primary Outcome Measure Information:
Title
Penetration-Aspiration Scale
Time Frame
at 6 weeks
Title
Videofluoroscopic dysphagia scale
Time Frame
at 6 weeks
Secondary Outcome Measure Information:
Title
Penetration-Aspiration Scale
Time Frame
at 12 weeks
Title
Videofluoroscopic dysphagia scale
Time Frame
at 12 weeks
Title
Peak Cough Flow
Time Frame
at 6 weeks, at 12 weeks
Title
Maximal Inspiratory Pressure
Time Frame
at 6 weeks, at 12 weeks
Title
Maximal Expiratory Pressure
Time Frame
at 6 weeks, at 12 weeks
Title
Forced vital capacity
Time Frame
at 6 weeks, at 12 weeks
Title
Forced expiratory volume
Time Frame
at 6 weeks, at 12 weeks
Title
Maximal phonation time
Time Frame
at 6 weeks, at 12 weeks
Title
Swallowing disturbance questionnaire
Time Frame
at 6 weeks, at 12 weeks
Title
Swallowing Quality of Life questionnaire
Time Frame
at 6 weeks, at 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age >19 years Clinically diagnosed with MSA according to the guidelines of the 2nd consensus of the Gilman criteria Clinically diagnosed to have dysphagia by a physiatrist Two or more points on the Penetration-aspiration scale (PAS) from the Videofluoroscopic swallowing study (VFSS) conducted within 3 months Exclusion Criteria: Moderate to severe cognitive dysfunction with Mini-mental State Examination score < 19 Comorbidities or structural abnormalities that may affect swallowing function Other comorbidities that make it difficult to participate in the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Han Gil Seo, MD, PhD
Phone
82-2-2072-1659
Email
hgseo80@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Han Gil Seo, MD, PhD
Organizational Affiliation
Seoul National University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Seoul National University Hospital
City
Seoul
ZIP/Postal Code
03080
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Han Gil Seo, MD, PhD
Phone
82-2-2072-1659
Email
hgseo80@gmail.com

12. IPD Sharing Statement

Learn more about this trial

Comprehensive Swallowing Rehabilitation in Patients With MSA

We'll reach out to this number within 24 hrs